Modulatory role of testosterone in plasma leptin turnover in rats

Endocrine - Tập 22 - Trang 203-210 - 2003
Daniel Castrogiovanni1, Mario Perelló1, Rolf C. Gaillard2, Eduardo Spinedi1
1Neuroendocrine Unit, Multidisciplinary Institute on Cell Biology (CONICET-CICPBA), La Plata, Argentina
2Division of Endocrinology, Diabetology & Metabolism, University Hospital (CHUV), Lausanne, Switzerland

Tóm tắt

We explored whether testosterone influences circulating leptin turnover in rats. Sham-operated male and female rats and 21-d gonadectomized rats treated or not treated with testosterone propionate were used. Anesthetized rats were implanted with an iv catheter, and then blood samples were drawn before and throughout a 60-min period following systemic leptin administration. Plasma testosterone, estradiol, and leptin concentrations were monitored. The results indicated that while gonadectomy blunted circulating concentrations of the homologous sex steroid, testosterone therapy, in gonadectomized rats, restored plasma testosterone concentrations to values found in normal male rats. Pharmacokinetic parameters evaluated during the test indicated the following: First, in the overall pharmacokinetic analyses, testosterone therapy in gonadectomized rats induced a more rapid disappearance of leptin from the circulation. Second, orchidectomy significantly enhanced the area under the curve (AUC) of circulating leptin, an effect fully reversed by testosterone treatment. Third, testosterone treatment in ovariectomized rats significantly decreased the AUC of leptin concentrations. Fourth, while gonadectomy alone did not modify circulating leptin half-life, conversely, testosterone therapy in gonadectomized rats decreased leptin half-life in the circulation. Finally, while orchidectomy reduced leptin body clearance, this parameter was increased by androgen therapy in gonadectomized rats. Our results strongly support that testosterone could play a main role in plasma leptin turnover by increasing leptin clearance rate and shortening plasma leptin half-life.

Tài liệu tham khảo

Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J. M. (1994). Nature 372, 425–432. Maffei, M., Halaas, J., Ravussin, E., et al. (1995). Nat. Med. 1, 1155–1161. Frederich, R. C., Hamann, A., Anderson, S., Lollman, B., Lowell, B. B., and Flier, J. S. (1995). Nat. Med. 1, 1311–1314. Zlokovic, B. V., Jovanovic, S., Miao, W., Samara, S., Verma, S., and Farrell, C. L. (2000). Endocrinology 141, 1434–1441. Schwartz, M. W., Seeley, R. L., Campfield, L. A., Burn, P., and Baskin, D. G. (1996). J. Clin. Invest. 98, 1101–1106. Hamann, A. and Matthaei, S. (1996). Exp. Clin. Endocrinol. Diabetes 104, 293–300. Hu, E., Tontonoz, P., and Spiegelman, B. M. (1995). Proc. Natl. Acad. Sci. USA 92, 9856–9860. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., and Spiegelman, B. M. (1994). Genes Dev. 8, 1224–1234. Grimaldi, P. (2001). Prog. Lipid Res. 40, 269–281. Cornelius, P., MacDougald, O. A., and Lane, M. D. (1994). Annu. Rev. Nutr. 14, 99–129. Smas, C. M. and Sul, H. S. (1995). Biochem. J. 309, 697–710. Lea-Currie, Y. R., Wen, P., and McIntosh, M. K. (1998). Biochem. Biophys. Res. Commun. 248, 497–504. Roncari, D. A. and Van, R. L. (1978). J. Clin. Invest. 62, 503–508. Wade, G. N. and Gray, J. M. (1978). Endocrinology 103, 1695–1701. Dieudonne, M. N., Pecquery, R., Boumediene, A., Leneveu, M. C., and Giudicelli, Y. (1998). Am. J. Physiol. 274, C1645-C1652. Rebuffe-Scrive, M., Enk, L., Crona, N., et al. (1985). J. Clin. Invest. 75, 1973–1976. Machinal, F., Dieudonne, M. N., Leneveu, M. C., Pecquery, R., and Giudicelli, Y. (1999). Endocrinology 140, 1567–1574. Wiesner, G., Vaz, M., Collier, G., et al. (1999). J. Clin. Endocrinol. Metab. 84, 2270–2274. Rosenbaum, M., Nicolson, M., Hirsch, J., et al. (1996). J. Clin. Endocrinol. Metab. 81, 3424–3427. Mulet, T., Pico, C., and Palou, A. (2003). Int. J. Biochem. Cell Biol. 35, 104–110. Rosenbaum, M., Pietrobelli, A., Vasselli, J. R., Heymsfield, S. B., and Leibel, R. L. (2001). Int. J. Obes. Relat. Metab. Disord. 25, 1365–1371. Jockenhovel, F., Blum, W. F., Vogel, E., et al. (1997). J. Clin. Endocrinol. Metab. 82, 2510–2513. Ghizzoni, L., Barreca, A., Mastorakos, G., et al. (2001). Horm. Metab. Res. 33, 323–328. Tena-Sempere, M., Manna, P. R., Zhang, F. P., et al. (2001). J. Endocrinol. 170, 413–423. Vila, R., Adan, C., Rafecas, A. I., Fernandez-Lopez, J. A., Remesar, X., and Alemany, M. (1998). Endocrinology 139, 4466–4469. Hill, R. A., Margetic, S., Pegg, G. G., and Gazzola, C. (1998). Int. J. Relat. Metab. Disord. 22, 765–770. Elbers, J. M., de Roo, G. W., Popp-Snijdes, C., et al. (1999). Clin. Endocrinol. (Oxf.) 51, 449–454. Wu-Peng, S., Rosenbaum, M., Nicolson, M., Chua, S. C., and Leibel, R. L. (1999). Obes. Res. 7, 586–592. Ashton, R. and Balment, R. J. (1991). Acta Endocrinol. (Copenh.) 124, 91–97. Sanchez-Capelo, A., Tejada, F., Ruzafa, C., Cremades, A., and Penafiel, R. (1999). Biol. Neonate 76, 72–83. Cumin, F., Baum, H.-P., and Levens, N. (1997). J. Endocrinol. 155, 577–585. Sharma, K., Considine, R. V., Michael, B., et al. (1997). Kidney Int. 51, 1980–1985. Cumin, F., Baum, H.-P., and Levens, N. (1996). Int. J. Obes. Relat. Metab. Disord. 20, 1120–1126. Lau, D., Mallard, S., Wariner, G., Watson, A., Cheung, E., and Young, J. (1996). Obes. Res. 4, 38S (abstract). Serradeil-Le Gal, C., Raufaste, D., Brossard, G., et al. (1997). FEBS Lett. 404, 185–191. Chan, J. L., Bluher, S., Yiannakouris, N., Suchard, M. A., Kratzsch, J., and Mantzoros, C. S. (2002). Diabetes 51, 2105–2112. Edmunds, S. E., Stubbs, A. P., Santos, A. A., and Wilkinson, M. L. (1990). J. Steroid Biochem. Mol. Biol. 37, 733–739. Sinha, M. K., Opentanova, I., Ohannesian, J. P., et al. (1996). J. Clin. Invest. 98, 1277–1282. Ertova, V., Haluzik, M., Svobodova, J., and Zivny, J. (2002). Ceska Gynekol. 67, 20–23. Kristensen, K., Pedersen, S. B., and Richelsen, B. (1999). Biochem. Biophys. Res. Commun. 259, 624–630. Bagnasco, M., Kalra, P. S., and Kalra, S. P. (2002). Neuroendocrinology 75, 257–263. Bennett, P. A., Lindell, K., Karlsson, C., Robinson, I. C. A. F., Carlsson, L. M. S., and Carlsson, B. (1998). Neuroendocrinology 67, 29–36. Fan, X. and Robaire, B. (1998). Endocrinology 139, 2128–2136. Porchet, H. C., Le Cottonec, J. Y., Neuteboom, B., Canali, S., and Zanolo, G. (1995). J. Clin. Endocrinol. Metab. 80, 667–673. Aronson, J. K., Dengler, H. J., Dettli, L., and Follath, F. (1988). Eur. J. Clin. Pharmacol. 35, 1–7. Gibaldi, M. and Perrier, D. (eds.). (1982). Pharmacokinetics. Marcel Dekker: New York. Daneva, T., Spinedi, E., Hadid, R., Jacquier, M.-J., Giacomini, M., and Gaillard, R. C. (1993). Mediat. Inflamm. 2, 123–127. Giovambattista, A., Chisari, A. N., Gaillard, R. C., and Spinedi, E. (2000). Neuroendocrinology 72, 341–349. McElroy, W. D. and Swanson, C. P. (eds.). (1974). Biostatistical analysis. Prentice-Hall: Englewood Cliffs, NJ.